These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

4414 related articles for article (PubMed ID: 6731586)

  • 1. Growth response of B16 melanoma to in vivo treatment with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) at the initial stage after tumor transplantation.
    Li XH; Paulus G; Atassi G; Buyssens N
    Am J Pathol; 1984 Jun; 115(3):403-11. PubMed ID: 6731586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy of a human malignant melanoma transplanted in the nude mouse.
    Povlsen CO; Jacobsen GK
    Cancer Res; 1975 Oct; 35(10):2790-6. PubMed ID: 1157050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of growth delay and cell survival as end-points of tumour response following treatment with combinations of cytotoxic agents.
    Stephens TC; Peacock JH
    Br J Cancer Suppl; 1980 Apr; 4():288-93. PubMed ID: 6932938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea by amphotericin B in murine ependymoblastoma.
    Laurent G; Atassi G; Hildebrand J
    Cancer Res; 1976 Nov; 36(11 Pt 1):4069-73. PubMed ID: 975049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of therapy on the antioxidant status in patients with melanoma.
    Gadjeva V; Dimov A; Georgieva N
    J Clin Pharm Ther; 2008 Apr; 33(2):179-85. PubMed ID: 18315784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thermochemotherapy for B16 melanoma: combination therapy of hyperthermia, melphalan, and CCNU in mice.
    Vicente V; Gomez M; Ochotorena MM; Cremades A; Canteras M
    Pigment Cell Res; 1990; 3(1):1-7. PubMed ID: 2377576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The response of hypoxic B16 melanoma cells to in vivo treatment with chemotherapeutic agents.
    Hill RP; Stanley JA
    Cancer Res; 1975 May; 35(5):1147-53. PubMed ID: 1120304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo potentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea by the radiation sensitizer benznidazole.
    Siemann DW; Morrissey S; Wolf K
    Cancer Res; 1983 Mar; 43(3):1010-3. PubMed ID: 6825075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraneoplastic injection of CCNU for experimental brain tumor chemotherapy.
    Tator CH
    Surg Neurol; 1977 Feb; 7(2):73-7. PubMed ID: 835077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour volume response, initial cell kill and cellular repopulation in B16 melanoma treated with cyclophosphamide and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
    Stephens TC; Peacock JH
    Br J Cancer; 1977 Sep; 36(3):313-21. PubMed ID: 921888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth support of small B16 melanoma implants with nitrosourea-sterilized fractions of the same tumor.
    Dykes DJ; Griswold DP; Schabel FM
    Cancer Res; 1976 Jun; 36(6):2031-4. PubMed ID: 1268854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo chemosensitization by misonidazole in sensitive and resistant tumor lines.
    Mulcahy RT; Siemann DW
    Cancer Res; 1983 Oct; 43(10):4709-13. PubMed ID: 6883329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid association improves the therapeutic index of lomustine [1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea] to suppress 36B-10 tumor growth in rats.
    Bethune CR; Geyer RJ; Spence AM; Ho RJ
    Cancer Res; 2001 May; 61(9):3669-74. PubMed ID: 11325837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of phenobarbital and high doses of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in the treatment of brain tumor-bearing mice.
    Muller PJ; Tator CH; Bloom ML
    Cancer Res; 1983 May; 43(5):2068-71. PubMed ID: 6831437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of RNA synthesis in murine ependymoblastoma by the combination of amphotericin B and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
    Laurent G; Dewerie-Vanhouche J; Machin D; Hildebrand J
    Cancer Res; 1980 Mar; 40(3):939-42. PubMed ID: 7471107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of quercetin on B16 melanotic melanoma growth in C57BL/6 mice and on activity of some acid hydrolases in melanoma tissue.
    Drewa G; Woźqak A; Pałgan K; Schachtschabel DO; Grzanka A; Sujkowska R
    Neoplasma; 2001; 48(1):12-8. PubMed ID: 11327532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium ascorbate enhancement of carbidopa-levodopa methyl ester antitumor activity against pigmented B16 melanoma.
    Pierson HF; Meadows GG
    Cancer Res; 1983 May; 43(5):2047-51. PubMed ID: 6831435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of tumorigenicity of B16 melanoma in heterogenetic mice by administration of copper chelates.
    Pierson HF
    Cancer Treat Rep; 1985 Nov; 69(11):1283-91. PubMed ID: 4092191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of scheduling of combinations of 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide and 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea on the Harding-Passey and Cloudman S91 mouse melanomas.
    Hill HZ; Hill GJ
    Cancer Res; 1982 Mar; 42(3):838-42. PubMed ID: 7059982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of various antineoplastic agents on an established human melanoma cell line (G-361).
    García Reverte JM; Bernabeu Esclapez A; Muñoz Ramos J; Vicente Ortega V; Canteras Jordana M
    Histol Histopathol; 1995 Jan; 10(1):79-84. PubMed ID: 7756747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 221.